14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
BLMN vs GENK: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Bloomin' Brands, Inc. (BLMN) is the stronger overall head-to-head candidate over GEN Restaurant Group, Inc. (GENK) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). BLMN carries a Unified Composite Score of 33.5/100 (SELL) at $9.97 (9.1x Forward P/E, 3.9% operating margin), whereas GENK carries 47.6/100 (HOLD) at $0.81 (N/M Forward P/E, -11.3% operating margin).
Composite vs. Pillar Nuance: While GENK currently prints a higher short-term Unified Composite Score (47.6/100 HOLD vs. BLMN 33.5/100 SELL), BLMN captures the overall institutional head-to-head verdict (9–1 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (3.9% vs. -11.3% operating margin) and revenue trajectory (+1.7% vs. -3.3% YoY).
Technical & Structure Timing Caution: BLMN is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.1); meanwhile GENK is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 26.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BLMN vs GENK. Trailing 12-month operating profitability (BLMN 3.9% vs GENK -11.3%) and valuation multiples (BLMN 9.1x vs GENK N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Restaurants value chain with $34.4M market capitalization and -11.3% operating margin.
OpEx & R&D Reinvestment20.0% of Rev ($42M)
90D Engineering Disclosures0 Published
Investor FAQ BLMN vs GENK Key Questions & Quantitative Answers
As of Nov 20, 2026, Bloomin' Brands, Inc. (BLMN) is the stronger overall head-to-head candidate over GEN Restaurant Group, Inc. (GENK) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). BLMN carries a Unified Composite Score of 33.5/100 (SELL) at $9.97 (9.1x Forward P/E, 3.9% operating margin), whereas GENK carries 47.6/100 (HOLD) at $0.81 (N/M Forward P/E, -11.3% operating margin). Composite vs. Pillar Nuance: While GENK currently prints a higher short-term Unified Composite Score (47.6/100 HOLD vs. BLMN 33.5/100 SELL), BLMN captures the overall institutional head-to-head verdict (9–1 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (3.9% vs. -11.3% operating margin) and revenue trajectory (+1.7% vs. -3.3% YoY). Technical & Structure Timing Caution: BLMN is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.1); meanwhile GENK is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 26.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
BLMN leads the Growth & Scale pillar: BLMN posts +1.7% YoY revenue growth and +22.4% YoY earnings growth on $4.00B TTM revenue (13.9% gross margin, 3.9% operating margin), compared with GENK at -3.3% YoY revenue growth and -93.6% YoY earnings growth on $208M TTM revenue (8.7% gross margin, -11.3% operating margin). On trailing 12-month operating scale, BLMN generates $4.00B in USD-normalized revenue versus $208M for GENK. In operating R&D and SG&A reinvestment, BLMN deploys 10.0% of Rev ($400M) (0 90-day corporate R&D disclosures) versus 20.0% of Rev ($42M) (0 disclosures) for GENK.
BLMN screens cheaper on headline valuation multiples. BLMN trades at 9.1x Forward P/E, 12.0x Trailing P/E, 1.07x PEG, and 0.7x EV/Revenue (3.0% FCF margin), whereas GENK trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.2x EV/Revenue (-6.7% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BLMN (19.9% ROE) versus GENK (-117.1% ROE) capital efficiency.
In options market volatility and institutional positioning, BLMN carries 60.7% implied volatility (40th %ile, Balanced (25th–60th %ile)), a 0.02x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.22β · 83% Vol realized risk). By comparison, GENK carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.91β · 132% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.